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Sub-Saharan Africa accounts for 69% of the people living
with HIV globally. An estimated 1,600,000 Kenyans are
living with HIV-1. Antiretroviral therapy (ART) has saved
9 million life-years in Sub-Saharan Africa. However, drug
resistance mutations reduce the effectiveness of ART, and
need to be monitored for effective ART. Naturally occur-
ring primary antiretroviral drug resistance mutations have
not been well analyzed in ART naïve HIV+ patients in
Kenya. Here we have examined protease inhibitor (PI)
resistance mutations in ART naïve HIV-1 seropositive
women in Pumwani sex worker cohort established in
Nairobi, Kenya, wherein HIV-1 infection is predominantly
caused by subtypes A and D viruses. We have analyzed
consensus sequences of HIV protease from 109 drug-
naïve patients, as a part of HIV-1 whole-genome sequen-
cing using 454 sequencing methodology. Analysis using
HIVdb program revealed a prevalence of 22% (24/109) PI
resistance mutations among the study subjects. D30N
(3.7%), M46I (0.9%) and V82F (0.9%) are the major
mutations observed. D30N mutation is known to con-
fer high-level resistance to nelfinavir. M46I and V82F
confer resistance to indinavir, lopinavir, fosamprenavir
and nelfinavir. In addition, many minor mutations
were found at seven different drug resistance sites. It is
important to study the implications of these mutations
to the effectiveness of specific PI drug treatment. This
study provides valuable data pertaining to primary drug
resistance in Kenyan HIV-1 infected patients before
ART became available.
Authors’ details
1Department of Medical Microbiology, University of Manitoba, Winnipeg,
Manitoba, Canada. 2Department of Medical Microbiology, University of
Nairobi, Nairobi, Kenya. 3National Microbiology Laboratory, Public Health
Agency of Canada, Winnipeg, Manitoba, Canada.
Published: 7 January 2014
doi:10.1186/1742-4690-11-S1-P133
Cite this article as: Sampathkumar et al.: Naturally occurring protease
inhibitor resistance mutations and their frequencies in HIV proviral
sequences of drug-naïve sex workers in Nairobi, Kenya. Retrovirology
2014 11(Suppl 1):P133.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: Ma.Luo@phac-aspc.gc.ca
1Department of Medical Microbiology, University of Manitoba, Winnipeg,
Manitoba, Canada
Full list of author information is available at the end of the article
Sampathkumar et al. Retrovirology 2014, 11(Suppl 1):P133
http://www.retrovirology.com/content/11/S1/P133
© 2014 Sampathkumar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
